Stocks · Health care · Pharmaceutical Preparations

MANNKIND CORP

MNKD Clue Score44
United States Fiscal year ends December CIK 0000899460
$3.13 -4.86% Close, 12 Oct 2026
Price $3.13 −39.92% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 13 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue174.8Operating income67.3Net income125.7EPS, diluted1.36Fiscal year 2017Revenue11.7 −93.3%Operating income−108.2Net income−117.3 −193.4%EPS, diluted−1.13Fiscal year 2018Revenue27.9 +137.2%Operating income−76.6Net income−87.0EPS, diluted−0.60Fiscal year 2019Revenue63.0 +126.3%Operating income−44.6Net income−51.9Fiscal year 2020Revenue65.1 +3.3%Operating income−47.9Net income−57.2EPS, diluted−0.26Fiscal year 2021Revenue75.4 +15.8%Operating income−47.0Net income−80.9EPS, diluted−0.32Fiscal year 2022Revenue99.8 +32.2%Operating income−64.1Net income−87.4EPS, diluted−0.34Fiscal year 2023Revenue199.0 +99.4%Operating income8.7Net income−11.9EPS, diluted−0.04Fiscal year 2024Revenue285.5 +43.5%Operating income72.6Net income27.6EPS, diluted0.10Fiscal year 2025Revenue349.0 +22.2%Operating income38.8Net income5.9 −78.7%EPS, diluted0.02
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 174.8 11.7 27.9 63.0 65.1 75.4 99.8 199.0 285.5 349.0
Growth −93.3% +137.2% +126.3% +3.3% +15.8% +32.2% +99.4% +43.5% +22.2%
Operating income 67.3 −108.2 −76.6 −44.6 −47.9 −47.0 −64.1 8.7 72.6 38.8
Net income 125.7 −117.3 −87.0 −51.9 −57.2 −80.9 −87.4 −11.9 27.6 5.9
Growth −193.4% −78.7%
EPS, diluted 1.36 −1.13 −0.60 n/a −0.26 −0.32 −0.34 −0.04 0.10 0.02

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin38.5%Net margin71.9%Free cash flow margin−45.3%Fiscal year 2017Operating margin−921.1%Net margin−999.0%Fiscal year 2018Operating margin−274.9%Net margin−312.2%Free cash flow margin−136.7%Fiscal year 2019Operating margin−70.7%Net margin−82.3%Free cash flow margin−144.4%Fiscal year 2020Operating margin−73.5%Net margin−87.9%Free cash flow margin−44.4%Fiscal year 2021Operating margin−62.3%Net margin−107.3%Free cash flow margin−97.0%Fiscal year 2022Operating margin−64.3%Net margin−87.6%Free cash flow margin−88.5%Fiscal year 2023Operating margin4.4%Net margin−6.0%Free cash flow margin−4.2%Fiscal year 2024Operating margin25.4%Net margin9.7%Free cash flow margin11.5%Fiscal year 2025Operating margin11.1%Net margin1.7%Free cash flow margin3.9%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin 38.5% −921.1% −274.9% −70.7% −73.5% −62.3% −64.3% 4.4% 25.4% 11.1%
Net margin 71.9% −999.0% −312.2% −82.3% −87.9% −107.3% −87.6% −6.0% 9.7% 1.7%
Free cash flow margin −45.3% n/a −136.7% −144.4% −44.4% −97.0% −88.5% −4.2% 11.5% 3.9%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−78.1Capital expenditure−1.1Free cash flow−79.2Fiscal year 2017Operating cash flow−64.8Fiscal year 2018Operating cash flow−37.7Capital expenditure−0.4Free cash flow−38.1Fiscal year 2019Operating cash flow−88.5Capital expenditure−2.6Free cash flow−91.0Fiscal year 2020Operating cash flow−28.1Capital expenditure−0.8Free cash flow−28.9Fiscal year 2021Operating cash flow−61.7Capital expenditure−11.5Free cash flow−73.2Fiscal year 2022Operating cash flow−80.7Capital expenditure−7.6Free cash flow−88.3Fiscal year 2023Operating cash flow34.1Capital expenditure−42.4Free cash flow−8.3Fiscal year 2024Operating cash flow42.5Capital expenditure−9.7Free cash flow32.8Fiscal year 2025Operating cash flow18.3Capital expenditure−4.6Free cash flow13.7 −58.3%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −78.1 −64.8 −37.7 −88.5 −28.1 −61.7 −80.7 34.1 42.5 18.3
Capital expenditure −1.1 n/a −0.4 −2.6 −0.8 −11.5 −7.6 −42.4 −9.7 −4.6
Free cash flow −79.2 n/a −38.1 −91.0 −28.9 −73.2 −88.3 −8.3 32.8 13.7
Growth −58.3%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash22.9Shareholders’ equity−183.6Fiscal year 2017Cash43.9Total debt156.8Net cash (debt)−112.9Shareholders’ equity−214.7Fiscal year 2018Cash71.2Total debt102.5Net cash (debt)−31.3Shareholders’ equity−175.1Fiscal year 2019Cash29.9Total debt118.9Net cash (debt)−89.0Shareholders’ equity−190.5Fiscal year 2020Cash67.0Total debt122.2Net cash (debt)−55.2Shareholders’ equity−180.4Fiscal year 2021Cash124.2Total debt281.2Net cash (debt)−157.0Shareholders’ equity−209.3Fiscal year 2022Cash69.8Total debt273.5Net cash (debt)−203.7Shareholders’ equity−250.5Fiscal year 2023Cash238.5Total debt268.7Net cash (debt)−30.2Shareholders’ equity−246.2Fiscal year 2024Cash46.3Total debt36.1Net cash (debt)10.3Shareholders’ equity−78.8Fiscal year 2025Cash74.9Total debt354.6Net cash (debt)−279.8Shareholders’ equity−51.0
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 22.9 43.9 71.2 29.9 67.0 124.2 69.8 238.5 46.3 74.9
Total debt n/a 156.8 102.5 118.9 122.2 281.2 273.5 268.7 36.1 354.6
Net cash (debt) n/a −112.9 −31.3 −89.0 −55.2 −157.0 −203.7 −30.2 10.3 −279.8
Shareholders’ equity −183.6 −214.7 −175.1 −190.5 −180.4 −209.3 −250.5 −246.2 −78.8 −51.0

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020† 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−78.1 −64.8 −37.7 −88.5 −28.1 −61.7 −80.7 34.1 42.5 18.3
Growth +24.7% −57.1%
2.4 1.8 n/a n/a n/a n/a n/a n/a n/a n/a
Investment
−1.1 n/a −0.4 −2.6 −0.8 −11.5 −7.6 −42.4 −9.7 −4.6
calc −79.2 n/a −38.1 −91.0 −28.9 −73.2 −88.3 −8.3 32.8 13.7
Growth −58.3%
calc −0.86 n/a −0.26 n/a −0.13 −0.29 −0.34 −0.03 0.12 0.04
−1.1 16.7 −0.2 −22.8 15.2 −151.5 4.9 −2.0 −96.6 −304.8
Financing
43.0 73.6 61.3 69.9 49.9 270.3 21.4 136.6 −137.3 315.1

† The diluted share count jumps at 2020, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.